Effects of simvastatin on plasma lipoproteins and hearing loss in apolipoprotein e gene-deficient mice

ORL

Volumn 71, Issue 5, 2009, Pages 244-250

  Cai, Qing ^a,d   Du, Xiaoping ^b   Zhou, Bin ^a   Cai, Chun ^a   Kermany, Mohammand Habiby ^a   Zhang, Chunxiang ^c   Yoo, Taijune ^a,b  

^a Neuroscience Institute   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^d RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Antilipid treatment; Atherosclerosis; Auditory dysfunction; Cochlea; Hair cells; Hyperlipidemia

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; GLUCOSE; LOW DENSITY LIPOPROTEIN; SIMVASTATIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; C57BL 6 MOUSE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HAIR CELL; HEARING LOSS; HISTOLOGY; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 3; INNER EAR; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; WILD TYPE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; FEMALE; HAIR CELLS, AUDITORY; HEARING LOSS, SENSORINEURAL; HYPERLIPIDEMIAS; LIPIDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SEVERITY OF ILLNESS INDEX; SIMVASTATIN;

EID: 69749084263     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000236014     Document Type: Article

References (38)

1. Rosen S, Plester D, El-Mofty A, Rosen HV: Relation of hearing loss to cardiovascular disease. Trans Am Acad Ophthalmol Otolaryngol 1964; 68: 433-444.
2. Rosen S, Olin P, Rosen HV: Diery prevention of hearing loss. Acta Otolaryngol 1970; 70: 242-247.
3. Rosen S, Olin P: Hearing loss and coronary heart disease. Arch Otolaryngol 1965; 82: 236-243.
4. Gates GA, Cobb JL, D'Agostino RB, Wolf PA: The relation of hearing in the elderly to the presence of cardiovascular disease and cardiovascular risk factors. Arch Otolaryngol Head Neck Surg 1993; 119: 156-161.
5. Jones NS, Davis A: A prospective case-controlled study of patients presenting with idiopathic sensorineural hearing loss to examine the relationship between hyperlipidaemia and sensorineural hearing loss. Clin Otolaryngol Allied Sci 1999; 24: 531-536. (Pubitemid 30006544)
6. Jones NS, Davis A: A retrospective case-controlled study of 1,490 consecutive patients presenting to a neuro-otology clinic to examine the relationship between blood lipid levels and sensorineural hearing loss. Clin Otolaryngol Allied Sci 2000; 25: 511-517.
7. Jones NS, Davis A: A prospective case-control study of 50 consecutive patients presenting with hyperlipidaemia. Clin Otolaryngol Allied Sci 2001; 26: 189-196.
8. Spencer JT Jr: Hyperlipoproteinemias in the etiology of inner ear disease. Laryngoscope 1973; 83: 639-678.
9. Pulec JL, Pulec MB, Mendoza I: Progressive sensorineural hearing loss, subjective tinnitus and vertigo caused by elevated blood lipids. Ear Nose Throat J 1997; 76: 716-720, 725- 726, 728.
10. Strome M, Topf P, Vernick DM: Hyperlipidemia in association with childhood sensorineural hearing loss. Laryngoscope 1988; 98: 165-169.
11. Suzuki K, Kaneko M, Murai K: Influence of serum lipids on auditory function. Laryngoscope 2000; 110: 1736-1738.
12. Kojima Y, Ito S, Furuya N: Hearing improvement after therapy for hyperlipidemia in patients with chronic-phase sudden deafness. Ann Otol Rhinol Laryngol 2001; 110: 105-108.
13. Morizono T, Paparella MM: Hypercholesterolemia and auditory dysfunction: Experimental studies. Ann Otol Rhinol Laryngol 1978; 87: 804-814.
14. Tami TA, Fankhauser CE, Mehlum DL: Effects of noise exposure and hypercholesterolemia on auditory function in the New Zealand white rabbit. Otolaryngol Head Neck Surg 1985; 93: 235-239.
15. Sikora MA, Morizono T, Ward WD, Paparella MM, Leslie K: Diet-induced hyperlipidemia and auditory dysfunction. Acta Otolaryngol 1986; 102: 372-381.
16. Satar B, Ozkaptan Y, Sürücü HS, Oztürk H: Ultrastructural effects of hypercholesterolemia on the cochlea. Otol Neurotol 2001; 22: 786-789.
17. Pillsbury HC: Hypertension, hyperlipoproteinemia, chronic noise exposure: Is there synergism in cochlear pathology? Laryngoscope 1986; 96: 1112-1138.
18. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 1992; 89: 4471-4475.
19. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992; 71: 343-353.
20. Bonthu S, Heistad DD, Chappell DA, Lamping KG, Faraci FM: Atherosclerosis, vascular remodeling, and impairment of endothelium- dependent relaxation in genetically altered hyperlipidemic mice. Arterioscler Thromb Vasc Biol 1997; 17: 2333-2340.
21. Lamping KG, Nuno DW, Chappell DA, Faraci FM: Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice. Am J Physiol 1999; 276:R1023-R1029.
22. Yang R, Powell-Braxton L, Ogaoawara AK, Dybdal N, Bunting S, Ohneda O, Jin H: Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 1999; 19: 2762-2768.
23. Kauser K, da Cunha V, Fitch R, Mallari C, Rubanyi GM: Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Physiol Heart Circ Physiol 2000; 278:H1679-H1685.
24. d'Uscio LV, Smith LA, Katusic ZS: Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein E-deficient mice. Stroke 2001; 32: 2658-2664.
25. d'Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, Katusic ZS: Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2001; 21: 1017-1022.
26. d'Uscio LV, Barton M, Shaw S, Lüscher TF: Chronic ET(A) receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein E-deficient mice. Cardiovasc Res 2002; 53: 487-495.
27. Masliah E, Mallory M, Ge N, Alford M, Veinbergs I, Roses AD: Neurodegeneration in the central nervous system of apoE-deficient mice. Exp Neurol 1995; 136: 107-122.
28. Oitzl MS, de Kloet ER, Joëls M, Schmid W, Cole TJ: Spatial learning deficits in mice with a targeted glucocorticoid receptor gene disruption. Eur J Neurosci 1997; 9: 2284-2296.
29. Niebauer J, Maxwell AJ, Lin PS, Tsao PS, Kosek J, Bernstein D, Cooke JP: Impaired aerobic capacity in hypercholesterolemic mice: Partial reversal by exercise training. Am J Physiol 1999; 276:H1346-H1354.
30. Hartley CJ, Reddy AK, Madala S, Martin- McNulty B, Vergona R, Sullivan ME, Halks- Miller M, Taffet GE, Michael LH, Entman ML, Wang YX: Hemodynamic changes in apolipoprotein E-knockout mice. Am J Physiol Heart Circ Physiol 2000; 279:H2326-H2334.
31. Guo Y, Zhang C, Du X, Nair U, Yoo TJ: Morphological and functional alterations of the cochlea in apolipoprotein E gene deficient mice. Hear Res 2005; 208: 54-67.
32. Zhu S, Du X, Cai Q, Guo Y, Liu L, Cheng W, Tao Z, Yoo T: Impaired stria vascularis in the inner ear of apolipoprotein E gene knockout mice. ORL J Otorhinolaryngol Relat Spec 2008; 70: 373-380.
33. Paigen B, Morrow A, Holmes PA: Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987; 68: 231-240.
34. Nissen SE, Tuzcu EM, Schoenhagen P: Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease, N Engl J Med 2005; 352: 29-38.
35. Chugh A, Ray A, Gupta JB: Squalene epoxidase as hypocholesterolemic drug target revisited. Progr Lipid Res 2003; 42: 37-50.
36. Morizono T, Sikora MA: Experimental hypercholesterolemia and auditory function in the chinchilla. Otolaryngol Head Neck Surg 1982; 90: 814-818.
37. Zheng Q: Mechanism of inner ear damage due to hyperlipidemia (in Chinese). Zhonghua Er Bi Yan Hou Ke Za Zhi 1989; 24: 75-78, 127.
38. Saito T, Sato K, Saito H: An experimental study of auditory dysfunction associated with hyperlipoproteinemia. Arch Otorhinolaryngol 1986; 243: 242-245.